Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Nicein (BM-600) in junctional epidermolysis bullosa: polyclonal antibodies provide new clues for pathogenic role.

Verrando P, Schofield O, Ishida-Yamamoto A, Aberdam D, Partouche O, Eady RA, Ortonne JP.

J Invest Dermatol. 1993 Nov;101(5):738-43.

2.

Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression.

Baudoin C, Miquel C, Blanchet-Bardon C, Gambini C, Meneguzzi G, Ortonne JP.

J Clin Invest. 1994 Feb;93(2):862-9.

3.

Basement membrane proteins kalinin and nicein are structurally and immunologically identical.

Marinkovich MP, Verrando P, Keene DR, Meneguzzi G, Lunstrum GP, Ortonne JP, Burgeson RE.

Lab Invest. 1993 Sep;69(3):295-9.

PMID:
8377472
4.

Keratinocytes from junctional epidermolysis bullosa do adhere and migrate on the basement membrane protein nicein through alpha 3 beta 1 integrin.

Verrando P, Lissitzky JC, Sarret Y, Winberg JO, Gedde-Dahl T Jr, Schmitt D, Bruckner-Tuderman L.

Lab Invest. 1994 Oct;71(4):567-74.

PMID:
7967512
6.

Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients.

Meneguzzi G, Marinkovich MP, Aberdam D, Pisani A, Burgeson R, Ortonne JP.

Exp Dermatol. 1992 Dec;1(5):221-9.

PMID:
1365323
7.

Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa.

Verrando P, Blanchet-Bardon C, Pisani A, Thomas L, Cambazard F, Eady RA, Schofield O, Ortonne JP.

Lab Invest. 1991 Jan;64(1):85-92.

PMID:
1990210
8.

GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: results of a multicenter study.

Schofield OM, Fine JD, Verrando P, Heagerty AH, Ortonne JP, Eady RA.

J Am Acad Dermatol. 1990 Dec;23(6 Pt 1):1078-83.

PMID:
2273105
9.

Altered expression of a new antigen of the dermal-epidermal junction (NU-T2 DEJ Ag) in junctional epidermolysis bullosa.

Tadini G, Kanitakis J, Cavalli R, Schmitt D, Cambiaghi S, Berti E.

Arch Dermatol Res. 1995;287(8):699-704.

PMID:
8554379
10.

Antigenic expression of integrin alpha 6 beta 4 in junctional epidermolysis bullosa.

Phillips RJ, Aplin JD, Lake BD.

Histopathology. 1994 Jun;24(6):571-6.

PMID:
8063286
11.

Expression of integrin alpha 6 beta 4 in junctional epidermolysis bullosa.

Jonkman MF, de Jong MC, Heeres K, Sonnenberg A.

J Invest Dermatol. 1992 Oct;99(4):489-96.

12.

Prenatal diagnosis of Herlitz junctional epidermolysis bullosa by amniocentesis.

Marinkovich MP, Meneguzzi G, Burgeson RE, Blanchet-Bardon C, Holbrook KA, Smith LT, Christiano AM, Ortonne JP.

Prenat Diagn. 1995 Nov;15(11):1027-34.

PMID:
8606881
13.

Defective integrin alpha 6 beta 4 expression in the skin of patients with junctional epidermolysis bullosa and pyloric atresia.

Brown TA, Gil SG, Sybert VP, Lestringant GG, Tadini G, Caputo R, Carter WG.

J Invest Dermatol. 1996 Sep;107(3):384-91. Erratum in: J Invest Dermatol 1997 Feb;108(2):237.

14.

Junctional epidermolysis bullosis: defects in expression of epiligrin/nicein/kalinin and integrin beta 4 that inhibit hemidesmosome formation.

Gil SG, Brown TA, Ryan MC, Carter WG.

J Invest Dermatol. 1994 Nov;103(5 Suppl):31S-38S. Review.

PMID:
7963682
15.

Lethal junctional epidermolysis bullosa with normal expression of BM 600 and antro-pyloric atresia: a new variant of junctional epidermolysis bullosa?

Lacour JP, Hoffman P, Bastiani-Griffet F, Boutte P, Pisani A, Ortonne JP.

Eur J Pediatr. 1992 Apr;151(4):252-7.

PMID:
1499575
16.

Deficiency of the integrin beta 4 subunit in junctional epidermolysis bullosa with pyloric atresia: consequences for hemidesmosome formation and adhesion properties.

Niessen CM, van der Raaij-Helmer MH, Hulsman EH, van der Neut R, Jonkman MF, Sonnenberg A.

J Cell Sci. 1996 Jul;109 ( Pt 7):1695-706. Erratum in: J Cell Sci 1996 Aug;109(Pt 8):precedi.

17.

Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5.

Kirtschig G, Marinkovich MP, Burgeson RE, Yancey KB.

J Invest Dermatol. 1995 Oct;105(4):543-8.

18.

Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands.

Yuen WY, Lemmink HH, van Dijk-Bos KK, Sinke RJ, Jonkman MF.

Br J Dermatol. 2011 Dec;165(6):1314-22. doi: 10.1111/j.1365-2133.2011.10553.x. Epub 2011 Nov 17.

PMID:
21801158
19.

Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.

McGrath JA, Ashton GH, Mellerio JE, Salas-Alanis JC, Swensson O, McMillan JR, Eady RA.

J Invest Dermatol. 1999 Sep;113(3):314-21.

20.

Supplemental Content

Support Center